DREAM Study Publications

  1. Hom MM, Asbell P, Barry B. Omegas and dry eye: More knowledge, more questions.  Optom Vis Sci 2015;92:948-56.
  2. Roy NS, Wei Y, Kuklinski E, Asbell PA. The growing need for validated biomarkers and endpoints for dry eye clinical research. Invest Ophthalmol Vis Sci 2017;58:BIO1–BIO19.  PMC5455411
  3. The Dry Eye Assessment and Management Study Research Group.  n-3 fatty acid supplementation for treatment of dry eye disease. N Engl J Med 2018;378:1681-1690. Epub 2018 Apr 13.  PMC5952353.
  4. Asbell PA, Maguire MG, Peskin E, Kuklinski E, Bunya VT, the DREAM Study Research Group. The Dry Eye Assessment and Management (DREAM©) Study: Study design and baseline characteristics.  Contemp Clin Trials 2018; 71:70-79. PMC7250048
  5. Bunya VY, Ying G-S, Maguire MG, Kuklinski E, Lin M, Peskin E, Asbell PA, DREAM Study Research Group. Prevalence of novel candidate Sjogren's Syndrome antibodies in the Dry Eye Assessment and Management (DREAM©) Study. Cornea 2018;37:1425-1430.  Epub 2018 Aug 29. PMC6173620.
  6. Daniel E, Maguire MG, Pistilli M, Bunya VY, Massaro-Giordano GM, Smith E, Kadakia PA, Asbell PA, the Dry Eye Assessment and Management Study.  Grading and baseline characteristics of meibomian glands in meibography images and their clinical associations in the Dry Eye Assessment and Management (DREAM) Study. Ocul Surf 2019;17:491-501. Epub 2019 Apr 22. PMC6708483.
  7. Szczotka-Flynn LB, Maguire MG, Ying G-S, Lin MC, Bunya VY, Dana R, Asbell PA. Impact of dry eye on visual acuity and contrast sensitivity: Dry Eye Assessment and Management Study.  Optom Vis Sci 2019;96:387-96. Epub 2019 May 20.  PMC6544497.
  8. Oydanich M; Maguire MG, Pistilli M; Hamrah P, Greiner JV, Lin MC, Asbell PA, the Dry Eye Assessment and Management (DREAM) Study Research Group. Effects of omega-3 supplementation on exploratory outcomes in the DREAM Study. Ophthalmology 2020;127:136-37.  Epub 2019 Jul 25. PMC6926153.
  9. Hussain M, Shtein RM, Pistilli M, Maguire MG, Oydanich M, Asbell PA, DREAM Research Group. The Dry Eye Assessment and Management (DREAM) extension study – A randomized clinical trial of withdrawal of supplementation with omega-3 fatty acid in patients with dry eye disease. Ocul Surf 2020;18:47-55. Epub 2019 Aug 16.  PMC7004875.
  10. Roy NS, Wei Y, Yu Y, Ying G-S, Kuklinski E, Barry B, Maguire MG, Dana R, Brightwell-Arnold M, Asbell PA, Dry Eye Assessment and Management (DREAM) Study Group. Conjunctival HLA-DR expression and its association with symptoms and signs in the DREAM study. Transl Vis Sci Technol 2019;8(4):31. PMC6707226.
  11. Kuklinski EJ, Hom MM, Ying GS, Lin MC, Chapkin R, Jones R, Moser A, Kim KY, Maguire  MG, Asbell PA. Associations between systemic omega-3 fatty acid levels with moderate to severe dry eye disease signs and symptoms at baseline in the Dry Eye Assessment and Management Study.  Eye Contact Lens 2021;47:2-7. Epub 2020 Feb 24. PMC7483206.
  12. Berg EJ, Ying GS, Maguire MG, Sheffield PE, Szczotka-Flynn LB, Asbell PA, Shen JF, the DREAM Study Research Group. Climatic and environmental correlates of dry eye disease severity: A report from the Dry Eye Assessment and Management (DREAM) Study.  Transl Vis Sci Technol2020;9(5):25. PMC7401914.
  13. Daniel E, Pistilli M, Ying G-S, Bunya VY, Massaro-Giordano M, Asbell PA, Maguire MG. Association of Meibomian gland morphology with symptoms and signs of dry eye disease in the Dry Eye Assessment and Management (DREAM) Study.  Ocul Surf 2020;18:761-769. Epub 2020 Aug 25.
  14. Greco G, Pistilli M, Asbell PA, Maguire MG, the Dry Eye Assessment & Management (DREAM) Study Research Group. Association of severity of dry eye disease with work productivity and activity impairment in the Dry Eye Assessment & Management Study. Ophthalmology 2021; 128:850-856. Epub 2020 14 Oct 14.
  15. Sayegh RR, Yu Y, Farrar JT, Kuklinski E, Shtein RM, Asbell PA, Maguire MG, the Dry Eye Assessment and Management (DREAM) Study Research Group. Ocular discomfort and quality of life among patients in the Dry Eye Assessment and Management (DREAM) Study. Cornea. 2021;7:869-875. 
  16. Yu K, Bunya V, Maguire M, Asbell P, Ying G-S. Systemic conditions associated with severity of dry eye signs and symptoms in the Dry Eye Assessment and Management (DREAM) Study. Ophthalmology. 2021 Mar 27;S0161-6420(21)00235-9. doi: 10.1016/j.ophtha.2021.03.030. Online ahead of print.
  17. Sutphin JE, Ying Correlation GS, Bunya VY, Yu Y, Lin MC, McWilliams K, Schmucker D, Kuklinski EJ, Asbell PA, Maguire MG. Association of keratographic and clinical Assessments of dry eye disease in the DRy Eye Assessment and Management (DREAM) Study. Cornea.  Cornea. 2021 Jul 22. doi: 10.1097/ICO.0000000000002804. [Online ahead of print]. PMID: 3429463